Please assess the completion status of the following clinical trial:

Trial Title: Reversal of Ventricular Remodeling With Toprol-XL

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of stable asymptomatic heart failure.~* Documented ejection fraction less than 0.40.~* Must be able to comply with all study procedures.~Exclusion Criteria:~* Taken B-blocker therapy for longer than 1 week within 6 months prior to randomization.~* Have heart problems that would not allow B-blocker therapy.~* Receiving B-blockers therapy for any medical reason including topical B-blockers that might cause systemic absorption (e.g., glaucoma).~* Undergone certain heart surgeries, such as, prior heart transplant or cardiomyoplasty.~* Have certain heart diseases.~* Pregnant or breast feeding.~* Unlikely to survive.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).